Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,499 INR | +3.43% |
|
+4.20% | +0.78% |
05-29 | India's Deepak Fertilisers And Petrochemicals's Q4 profit falls on weak demand | RE |
05-22 | Meera Industries Bags INR74.7 Million Order for Ring Twisting Machines from SRF; Meera Shares Jump 7% | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 41.9 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.78% | 8.59B | C- | ||
+4.51% | 77.12B | B | ||
+4.93% | 33.75B | C | ||
+15.37% | 19.01B | B | ||
+10.22% | 11.64B | A- | ||
-22.49% | 9.99B | B | ||
-6.46% | 9.97B | - | ||
-5.91% | 8.8B | A- | ||
-1.54% | 7.54B | B | ||
-13.07% | 5.64B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SRF Stock
- Ratings SRF Limited